BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32193104)

  • 1. The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro.
    Lima ÉA; Cavalcante-Silva LHA; Carvalho DCM; Netto CD; Costa PRR; Rodrigues-Mascarenhas S
    Int Immunopharmacol; 2020 Jun; 83():106399. PubMed ID: 32193104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory properties of pterocarpanquinone LQB-118 in mice.
    Riça IG; Netto CD; Rennó MN; Abreu PA; Costa PRR; da Silva AJM; Cavalcante MCM
    Bioorg Med Chem; 2016 Sep; 24(18):4415-4423. PubMed ID: 27492193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marinobufagenin Inhibits Neutrophil Migration and Proinflammatory Cytokines.
    Carvalho DCM; Cavalcante-Silva LHA; Lima ÉA; Galvão JGFM; Alves AKA; Feijó PRO; Quintas LEM; Rodrigues-Mascarenhas S
    J Immunol Res; 2019; 2019():1094520. PubMed ID: 31236418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
    Pan Q; Liu Y; Zheng J; Lu X; Wu S; Zhu P; Fu N
    Int Immunopharmacol; 2010 Aug; 10(8):967-77. PubMed ID: 20669364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitexin reduces neutrophil migration to inflammatory focus by down-regulating pro-inflammatory mediators via inhibition of p38, ERK1/2 and JNK pathway.
    Rosa SI; Rios-Santos F; Balogun SO; Martins DT
    Phytomedicine; 2016 Jan; 23(1):9-17. PubMed ID: 26902402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forsythoside A Modulates Zymosan-Induced Peritonitis in Mice.
    Zhang XT; Ding Y; Kang P; Zhang XY; Zhang T
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29509714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model.
    Lai X; Ye Y; Sun C; Huang X; Tang X; Zeng X; Yin P; Zeng Y
    Int Immunopharmacol; 2013 May; 16(1):41-9. PubMed ID: 23566810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal mesothelial cells produce inflammatory related cytokines.
    Yao V; Platell C; Hall JC
    ANZ J Surg; 2004 Nov; 74(11):997-1002. PubMed ID: 15550091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-inflammatory and mechanism of action of extract of Macrosiphonia longiflora (Desf.) Müll. Arg.
    da Silva AO; Damaceno Alves A; Almeida DA; Balogun SO; de Oliveira RG; Aires Aguiar A; Soares IM; Marson-Ascêncio PG; Ascêncio SD; de Oliveira Martins DT
    J Ethnopharmacol; 2014 Jun; 154(2):319-29. PubMed ID: 24681039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of zymosan-induced peritonitis by riboflavin co-injection, pre-injection or post-injection in male Swiss mice.
    Mazur-Bialy AI; Kolaczkowska E; Plytycz B
    Life Sci; 2012 Dec; 91(25-26):1351-7. PubMed ID: 23123448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
    Martino T; Kudrolli TA; Kumar B; Salviano I; Mencalha A; Coelho MGP; Justo G; Costa PRR; Sabino KCC; Lupold SE
    Prostate; 2018 Feb; 78(2):140-151. PubMed ID: 29105806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anti-inflammatory activity of hydroethanolic extract of Dilodendron bipinnatum Radlk.
    de Oliveira RG; Mahon CP; Ascêncio PG; Ascêncio SD; Balogun SO; de Oliveira Martins DT
    J Ethnopharmacol; 2014 Aug; 155(1):387-95. PubMed ID: 24930355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morita-Baylis-Hillman Adduct 2-(3-Hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN) Modulates Inflammatory Process In vitro and In vivo.
    de França JS; de Sales-Neto JM; Carvalho DCM; de Almeida Lima É; Olegário TR; Mendes RKS; Lima-Junior CG; de Almeida Vasconcellos MLA; Rodrigues-Mascarenhas S
    Inflammation; 2021 Jun; 44(3):899-907. PubMed ID: 33236262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory potential of pyocyanin in LPS-stimulated murine macrophages.
    Marreiro de Sales-Neto J; Lima ÉA; Cavalcante-Silva LHA; Vasconcelos U; Rodrigues-Mascarenhas S
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):102-108. PubMed ID: 30623710
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo antineoplastic and immunological effects of pterocarpanquinone LQB-118.
    Salustiano EJ; Dumas ML; Silva-Santos GG; Netto CD; Costa PR; Rumjanek VM
    Invest New Drugs; 2016 Oct; 34(5):541-51. PubMed ID: 27189479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
    Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
    Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis.
    Bellavita R; Raucci F; Merlino F; Piccolo M; Ferraro MG; Irace C; Santamaria R; Iqbal AJ; Novellino E; Grieco P; Mascolo N; Maione F
    Biomed Pharmacother; 2020 Mar; 123():109788. PubMed ID: 31865142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase negatively regulates the expression of proinflammatory cytokines and chemokines by zymosan-induced mouse neutrophils.
    Endo D; Saito T; Umeki Y; Suzuki K; Aratani Y
    Inflamm Res; 2016 Feb; 65(2):151-9. PubMed ID: 26573963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new acyl derivative of sulfadimethoxine inhibits phagocyte oxidative burst and ameliorates inflammation in a mice model of zymosan-induced generalised inflammation.
    Baig TA; Haniffa HM; Siddiqui H; Shah SF; Jabeen A
    Inflammopharmacology; 2023 Dec; 31(6):3303-3316. PubMed ID: 37971604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation.
    Brando Lima AC; Machado AL; Simon P; Cavalcante MM; Rezende DC; Sperandio da Silva GM; Nascimento PG; Quintas LE; Cunha FQ; Barreiro EJ; Lima LM; Koatz VL
    Pharmacol Rep; 2011; 63(4):1029-39. PubMed ID: 22001991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.